Lipoprotein ratio linked to poor survival in metastatic RCCDecember 11, 2018Renal Cell CarcinomaGenitourinary Cancer
RCC strongly linked to melanoma, and vice versaDecember 10, 2018Renal Cell CarcinomaGenitourinary CancerMelanoma
hTERT expression predicts RCC survival, tumor aggressivenessDecember 4, 2018Renal Cell CarcinomaGenitourinary Cancer
Age-related gene expression may affect responses to RCC therapyDecember 4, 2018Renal Cell CarcinomaImmunotherapyGenitourinary CancerImmuno-oncology
Clear cell RCC with papillary features is still ccRCCDecember 4, 2018Renal Cell CarcinomaGenitourinary Cancer
Stereotactic radiotherapy highly effective for brain mets in RCCNovember 30, 2018Renal Cell CarcinomaGenitourinary CancerCNS/Brain Cancer
BAP1 expression augurs prognosis of metastatic RCCNovember 19, 2018Renal Cell CarcinomaGenitourinary Cancer
PD-L1 correlates with worse sporadic, hereditary ccRCC outcomesNovember 19, 2018Renal Cell CarcinomaImmuno-oncologyGenitourinary Cancer
Abiraterone also benefits low-risk metastatic prostate cancer patientsNovember 13, 2018Genitourinary Cancer
Refractory immune-mediated colitis: Fecal transplant may be the answerNovember 12, 2018Immuno-oncologyGenitourinary CancerRenal Cell CarcinomaPatient & Survivor Care
SRS beats surgery in early control of brain mets, advantage fades with timeNovember 9, 2018CNS/Brain CancerBreast CancerMelanomaGastroenterologyGenitourinary CancerRenal Cell CarcinomaGastrointestinal Cancer
Circulating tumor DNA identified by fragment sizeNovember 7, 2018Gynecologic CancerGenitourinary CancerBreast CancerRenal Cell CarcinomaCNS/Brain CancerMelanoma
Tumor burden in active surveillance for mRCC may inform treatment decisionsNovember 6, 2018Renal Cell CarcinomaGenitourinary Cancer
Striking racial/ethnic differences seen in RCC featuresNovember 5, 2018Renal Cell CarcinomaGenitourinary Cancer
